Epstein Secrets

or marked FSH TNP 1.5-12.4 mIU/mt fl 6.8 01/27/2016 Test Not Performed: Specimen rejected for testing due hemolysis. to moderate or marked PROLACTIN, SERUM TNP 4.0-15.2 ng/mL 3.0 LO 101/27/2016 lest Not Performed: Specimen rejected for testing due hemolysis. to moderate or marked ESTRADIO

f the presence or absence of malignant disease. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics) PSA, FREE TNP Not Estab. ng/mL Test Not Performed: Specimen rejected for testing due to moderate or marked hemolysis. 0.70 101/27/2016 NOTE: Results cannot be interpre

ot contain all abnormal results; narrative results may not have abnormal flags. Please review entire report.) Triglycerides INTR.NORM. RATIO(INR) PROLACTIN, SERUM 459 HI 0.97 LO 3.0 LO HDL CHOL., DIRECT 24 LO Hemoglobin A1C 6.0 HI * CHEMISTRY * Test Result Abnormal e erence In s •rev ous

the presence or absence of malignant disease. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics) PSA, FREE 0.33 Not Estab. ng/mL I 0.31 10/27/201S BioReference Laboratories, Inc. Elmwood Park, NJ 07407 James Weisberger M.D. Page 3 of S Laboratory Director Prin

27/2016 FSH TOP Test Not Performed: Specimen rejected for testing due hemolysis. 1.5-12.4 mIU/ral. 1 to moderate or marked 6.8 101/27/2016 PROLACTIN, SERUM TIP Test Not Performed: Specimen rejected for testing due hemolysis. 4.0-15.2 ng/ml. to moderate or marked 3.0 LO 101/27/2016 ESTRADI

th different assay methods or kits cannot be interchangeably. ASSAY INFORMATION: Method Electrocheedluninescence Immunoassay (Roche Diagnostics). Not Estab. ng/mi. to moderate or marked of the obtained used 1 0.33 101/27/2016 % FREE PSA TNP FREE PSA RISK ASSESSMENT The probability of prostate